{"name":"ViroXis Corporation","slug":"viroxis-corporation","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMizwJBVV95cUxNeUpIQXNZVy04VUptaGd1dDRMa1YwWjRHQTdsUXg2R1RuV0xlX2g5M1diZFpXNmszX1pIMjJ6SERvcmpaN1RlRmtBSWtITVVMVERMcU55UHVsZzUxTDRoVVhsZ3lpQmJVM2psYzRWZ0ZzbTF1YzJKcUM2WDRXNlJtQTZOb1NXSDJkUW9kZl9iUXE0SDNMX2htMklDd2dGNmlCbkN1c2ZpOVp2VlNzZzItS1ZBSUstclUyQ1IxcHVKYTkwUDQxRl94eVRLZnlRVEN2RGtBbnkyalNINEJucV96Vy1XTXpDWk9IdGdPdWVOVkZadGVvY21hYlRGLTdJSklnNGpuSmNKX0ZwcTJuSmJtbmJhQUtrTmthQkVINmtoWFVUWEU1ZmJZU1IwTklKX3N4Tm5rVGtuN1NMQWFqbFQ1YXh2dVZmWENTemthWm1IZw?oc=5","date":"2026-04-07","type":"regulatory","source":"Barchart.com","summary":"Common Warts Treatment Market Outlook 2034: Insights on Clinical Trials, FDA/EMA/PMDA Approvals, NDA Progress, Therapeutics, Disease Prevalence, Mechanisms, Market Size, Key Companies | DelveInsight -","headline":"Common Warts Treatment Market Outlook 2034: Insights on Clinical Trials, FDA/EMA/PMDA Approvals, NDA Progress, Therapeut","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxNTlNUMDVON0lvSzhreTBCd04xVzFyRk5rZ2VKYUxxWTA1YWpkQU8yS1FNakotc3B5MkkybUdhc2s2XzNtR2FFWndOaHZFb0NMbzNRbUoteVEyV0hUTjdwZ3BmN3dwUzAxVUdWck5JOWNCMWdBWEs3RUNFUjlwVkVGenZ0Sk5SanR6SkRLaDZhdU9zNEtHR3c?oc=5","date":"2026-04-06","type":"earnings","source":"openPR.com","summary":"Common Warts Market: Expanding Revenue Landscape to 2034 - DelveInsight - openPR.com","headline":"Common Warts Market: Expanding Revenue Landscape to 2034 - DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxQczZ4M09mM0Z3ZDJlVzhKWkV1V2V0SmJUcEpQallPR0w3VG9vaTZOWDNXUERlVlBmQ0lpcHNmUGthWllMYnc0c241RUJMTGNEaXBwUFBhTkRjTlhhQ3R0dFlyUW1wWURfVmtQZDVvQlIxTm1MRlBhMVgzSWE3WDBqSzExWnlhanBNSi0tZUtyQkJrdVBRSGFPZUE0dw?oc=5","date":"2026-03-24","type":"trial","source":"openPR.com","summary":"Genital Herpes Clinical Trial Pipeline Shows Potential with Active Contributions from 18+ Key Companies | DelveInsight - openPR.com","headline":"Genital Herpes Clinical Trial Pipeline Shows Potential with Active Contributions from 18+ Key Companies | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxOYzc3YWZ4Umk3SHVtSk5nSU1hZ1BxaGNiY0FkeVFYTFo2c3VyLXJ4eDZqSWZybG5oYmQweVhYTVBGTk5reDJCN0xnOUFEbzFwdk1jWXdYVU5Kb0VJR0I4b0EyLVByN3RVNFFMcm9FamJnRFI3dUIzVlRmQnAtazQzTGZiWGlOb0NUV0FEZWh5UXJnRGtWTTFCQUFTZkpES29jR19KeEEzNFpUVjA?oc=5","date":"2015-06-19","type":"deal","source":"Australian Broadcasting Corporation","summary":"Australian sandalwood producer buys US drug companies - Australian Broadcasting Corporation","headline":"Australian sandalwood producer buys US drug companies","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}